Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients
Sponsored by Singapore General Hospital
About this trial
Last updated 3 years ago
Study ID
2021/2434
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
21+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
The study aims to examine the use of hydrocolloid dressing for catheter exit-site care in
peritoneal dialysis patients. It is a pilot study, and participants will be randomized to
either receiving weekly hydrocolloid dressing or daily topical gentamicin cream for exit-site
care in peritoneal dialysis patients.
What are the participation requirements?
Inclusion Criteria
- All adult peritoneal dialysis patients (≥ 21 years old) and are followed up at Singapore General Hospital (SGH)
Exclusion Criteria
- Patients who are unable to provide valid consent, patients who have known allergy to hydrocolloid dressing, patients who have peritoneal dialysis catheter exit site infection or peritonitis within the past 3 months, patients who have dialysate leak at PD catheter exit site, pregnant women, patients with life-expectancy of < 1 year or patients who are currently involved in another study for peritoneal dialysis catheter exit site care.
Locations
Location
Status
Recruiting